This hypothesis is further supported by the continuous increase of ERCC1 levels with the number of deletions detected, suggesting high level activity of replication associated DNA damage repair mechanisms in subsets of prostate cancer with generation of chromosomal aberration via DSB formation and faulty repair. The gene discussed is ERCC1; the disease is prostate carcinoma.